Bristol-Myers Squibb
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $12,222,000 | $12,269,000 | $11,201,000 | $12,342,000 |
Gross Profit | 8,787,000 | 8,070,000 | 7,340,000 | 7,424,000 |
EBITDA | 4,587,000 | 3,287,000 | 4,477,000 | 2,551,000 |
EBIT | 3,594,000 | 2,258,000 | 3,465,000 | 671,000 |
Net Income | 2,201,000 | 1,310,000 | 2,456,000 | 72,000 |
Net Change In Cash | 12,222,000 | 12,269,000 | 11,201,000 | 12,342,000 |
Free Cash Flow | 5,991,000 | 3,556,000 | 1,694,000 | 4,061,000 |
Cash | 15,726,000 | 12,599,000 | 10,875,000 | 10,346,000 |
Basic Shares | 2,037,963 | 2,038,000 | 2,037,000 | 2,037,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $48,300,000 | $45,006,000 | $46,159,000 | $46,385,000 |
Gross Profit | 27,432,000 | 25,357,000 | 26,490,000 | 26,761,000 |
EBITDA | 3,168,000 | 19,366,000 | 19,221,000 | 20,118,000 |
EBIT | -6,432,000 | 9,606,000 | 8,945,000 | 9,432,000 |
Net Income | -8,948,000 | 8,025,000 | 6,327,000 | 6,994,000 |
Net Change In Cash | 48,300,000 | 45,006,000 | 46,159,000 | 46,385,000 |
Cost of Revenue | -4,958,000 | -555,000 | ||
Free Cash Flow | 13,942,000 | 12,651,000 | 11,948,000 | 15,234,000 |
Cash | 10,346,000 | 11,464,000 | 9,123,000 | 13,979,000 |
Basic Shares | 2,027,000 | 2,078,000 | 2,146,000 | 2,245,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $1.63 |
2025-06-30 | $1.46 |
2025-03-31 | $1.80 |
